Curza is a small-molecule therapeutics company that has developed several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. Curza’s lead program is a new class of broad spectrum antibiotics, focused on ESKAPE pathogens and drug-resistant Gram-negative bacteria. Inspired by a natural product, thisclass targets an unexploited binding site of the bacterial ribosome. With ever increasing reports of resistance to frontline therapies addressing Gram-negative bacteria, there is a critical need for new therapies and new therapies that work in new ways. However, very little can be found in the development pipeline. As a result, Curza’s compounds are addressing a major unmet medical need.

Biotechnology

Health Care

Therapeutics

Curza

Curza's headquarters in Salt Lake City, UT, United States

This department focuses on innovation and the advancement of scientific knowledge through research initiatives.

Research and Development

This department is responsible for setting the strategic direction and overall governance of the organization.

Executive Leadership

This department oversees both research initiatives and financial management to drive strategic growth and innovation.

Discovery and Finance

This department focuses on the design and development of pharmaceutical compounds through chemical research and analysis.

People (2)

Jobs (0)

Other teams

Executive Leadership

Discovery and Finance

Medicinal Chemistry